Emergent BioSolutions EBS
NYSE EBS
$6.09 -0.01 (-0.16%)
As of: Nov 10, 2026 · 12:50 PM EST

Emergent BioSolutions (EBS) Receivables - Net (2010 - 2026)

Updated

Analysis

Emergent BioSolutions (EBS) Receivables - Net (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Emergent BioSolutions 310.37 Mn -370.73 Mn 29.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 77.50 Mn
Jun 30, 2026 190.00 Mn
Mar 31, 2026 121.60 Mn
Dec 31, 2025 84.20 Mn
Sep 30, 2025 149.50 Mn
Jun 30, 2025 79.80 Mn
Mar 31, 2025 203.70 Mn
Dec 31, 2024 154.50 Mn
Sep 30, 2024 121.30 Mn
Jun 30, 2024 196.30 Mn
Mar 31, 2024 233.50 Mn
Dec 31, 2023 191.00 Mn
Sep 30, 2023 216.50 Mn
Jun 30, 2023 290.10 Mn
Mar 31, 2023 155.90 Mn
Dec 31, 2022 159.20 Mn
Sep 30, 2022 189.20 Mn
Jun 30, 2022 175.00 Mn
Mar 31, 2022 181.80 Mn
Dec 31, 2021 278.90 Mn
API Access

Emergent BioSolutions Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=EBS&period=max&api_key=YOUR_API_KEY